Mode
Text Size
Log in / Sign up

Glioblastoma with transdural extension and skull base involvement presents as a rare clinical scenarioCase Report Shows Treatment Success for Rare Glioblastoma Presentation

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the importance of integrating MRI, MRS, and molecular profiling for glioblastoma with transdural extension.

This case report and literature review describes a rare presentation of glioblastoma characterized by transdural extension and skull base involvement. The report details the clinical course of a 63-year-old male who underwent gross total resection, cranioplasty, and concurrent temozolomide with radiotherapy (60 Gy/30 fractions to tumor bed; 54 Gy/30 fractions to low-risk field).

Histopathology confirmed glioblastoma (CNS WHO grade 4) with a molecular profile including IDH-wildtype, TERT promoter mutation, CDKN2A/CDKN2B homozygous deletion, PTEN loss, chromosome 10 loss, and MGMT promoter unmethylation. At the 3-month follow-up, the patient was alive without radiographic progression or new neurological deficits, with reported relief of headache.

The authors note that while the case highlights the importance of integrating MRI, MRS, histopathology, and molecular profiling for diagnosis, the evidence is limited by a single case report. The findings underscore the complexity of glioblastoma involving dural contact and skull base involvement but do not provide broad statistical conclusions.

How this fits prior evidence

This case report addresses a gap in clinical documentation regarding rare presentations of glioblastoma with transdural extension and skull base involvement. While prior coverage noted that most glioblastoma progressions occur within the local field, this case highlights how specific anatomical involvements like dural contact may influence presentation. It also complements findings on gross total resection rates by illustrating a successful surgical and chemotherapeutic outcome in a complex anatomical location.

This report describes a single case of glioblastoma, a serious type of brain cancer. In this specific instance, the tumor was located near the skull base and extended through the bone. The patient underwent a full surgical removal of the tumor, followed by radiation therapy and chemotherapy with temozolomide.

At the three-month follow-up, the patient remained alive without new neurological issues or signs of the cancer spreading on scans. The treatment also successfully relieved the patient's headaches. Doctors used several tools, including MRI scans and molecular profiling, to understand the tumor's specific characteristics.

It is important to note that this information comes from a single case report rather than a large clinical trial. Because the sample size is very small, these results cannot be applied to everyone with glioblastoma. This case highlights how specialized imaging and testing can help doctors manage complex cases involving skull base involvement.

What this means for you:
A single case shows successful management of a rare glioblastoma type using surgery, radiation, and chemotherapy.

Common questions

What was the treatment for this specific brain tumor?

The patient underwent a gross total resection of the intracranial tumor and skull lesion. This was followed by radiotherapy (60 Gy/30 fractions to the tumor bed and 54 Gy/30 fractions to the low-risk field) and concurrent and adjuvant temozolomide chemotherapy.

What were the results for the patient after three months?

At the three-month follow-up, the patient was alive without radiographic progression. The treatment also resulted in a relief of headaches and no new neurological deficits were reported during that period.

Is this finding applicable to all patients with glioblastoma?

Because this is a single case report, the findings are not enough to say it will work for everyone. It highlights a rare presentation of glioblastoma and shows how specific tools like MRI and molecular profiling help doctors manage complex cases.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BackgroundGlioblastoma (GBM) is the most common and most aggressive primary malignant tumor of the central nervous system in adults. Although GBM is characterized by highly infiltrative growth within the brain parenchyma, spontaneous transdural extension with direct invasion of the calvarium and skull base at initial presentation is exceptionally rare. Such cases may radiologically mimic metastatic skull tumors or other extra-axial lesions, creating diagnostic and therapeutic challenges.Case presentationWe report the case of a 63-year-old man who presented with dizziness, slowed responses, and progressive gait impairment. Magnetic resonance imaging revealed a heterogeneously enhancing right temporal lobe mass with marked peritumoral edema, while computed tomography demonstrated contiguous osteolytic destruction of the right temporal calvarium and mastoid region. Magnetic resonance spectroscopy showed a markedly elevated choline peak, reduced N-acetylaspartate, and increased lipid/lactate peak, supporting a high-grade infiltrative glioma. The patient underwent gross total resection of the intracranial tumor together with resection of the involved skull lesion and cranioplasty. Histopathology confirmed glioblastoma, CNS WHO grade 4. Molecular testing demonstrated an IDH-wildtype profile with TERT promoter mutation, CDKN2A/CDKN2B homozygous deletion, PTEN loss, chromosome 10 loss, MGMT promoter unmethylation, and absence of 1p/19q codeletion. Postoperatively, the patient received radiotherapy to the tumor bed (60 Gy/30 fractions) and surrounding low-risk field (54 Gy/30 fractions) with concurrent temozolomide, followed by adjuvant temozolomide. Early postoperative MRI indicated gross total resection. At 3-month follow-up, the patient remained alive without radiographic progression, with relief of headache and no new neurological deficits.ConclusionThis case highlights an exceptionally rare presentation of primary IDH-wildtype glioblastoma with spontaneous transdural extension and contiguous calvarial/mastoid osteolysis before any cranial intervention. In addition to expanding the clinicoradiological spectrum of GBM, this case underscores the diagnostic value of integrating MRI, MRS, histopathology, and molecular profiling in skull-invasive lesions. Our literature review suggests that superficially located tumors with prolonged dural contact may facilitate transdural spread, whereas molecular alterations associated with aggressive mesenchymal-like behavior and extracellular matrix remodeling may contribute to osseous invasion. This report adds a contemporary molecularly characterized example to the limited literature on skull-invasive GBM.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.